Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vera Therapeutics, Inc.

22.65
-0.6400-2.75%
Post-market: 22.650.00000.00%19:15 EDT
Volume:2.68M
Turnover:61.08M
Market Cap:1.44B
PE:-7.55
High:23.38
Open:23.19
Low:22.28
Close:23.29
Loading ...

BUZZ-Vera Therapeutics falls after kidney drug data from rival Otsuka

Reuters
·
06 Jun

Vera Therapeutics Shares Plunge 28% Premarket After Data From Rival Otsuka's Kidney Disease Drug

THOMSON REUTERS
·
06 Jun

VERA integrates cheqd’s decentralized identity stack to enable secure B2B communication 5 seconds ago

cryptonews
·
05 Jun

Vera Therapeutics Secures $500M Loan Agreement

TIPRANKS
·
03 Jun

Vera Therapeutics Inc - Enters $500 Mln Credit Facility With Oxford Finance

THOMSON REUTERS
·
03 Jun

Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans

THOMSON REUTERS
·
03 Jun

Press Release: Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans

Dow Jones
·
03 Jun

Analysts’ Opinions Are Mixed on These Healthcare Stocks: West Pharmaceutical Services (WST), Blueprint Medicines (BPMC) and Vera Therapeutics (VERA)

TIPRANKS
·
03 Jun

Small U.S. Stocks End Mixed As Vera Therapeutics Lead, Diginex Lags

Dow Jones
·
03 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Natgas companies, UnitedHealth, Cactus

Reuters
·
03 Jun

Vera Therapeutics Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
03 Jun

Wedbush Raises Price Target on Vera Therapeutics to $32 From $26, Maintains Neutral Rating

MT Newswires Live
·
03 Jun

J.P. Morgan Remains a Buy on Vera Therapeutics (VERA)

TIPRANKS
·
02 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Lyra Therapeutics, Church & Dwight, Applied Digital

Reuters
·
02 Jun

Vera Therapeutics price target raised to $65 from $55 at Scotiabank

TIPRANKS
·
02 Jun

Vera Therapeutics (VERA) Receives a Buy from Guggenheim

TIPRANKS
·
02 Jun

Evercore ISI Reaffirms Their Buy Rating on Vera Therapeutics (VERA)

TIPRANKS
·
02 Jun

Buy Rating for Vera Therapeutics: Promising Potential of Atacicept in IgA Nephropathy Treatment

TIPRANKS
·
02 Jun

Vera Therapeutics Shares Jump 64% After Kidney Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS
·
02 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Red Rock Resorts, Kymera

Reuters
·
02 Jun